Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires

From Yahoo Finance: 2025-04-11 16:11:00

In a recent article, we highlighted the 10 Best Medical Stocks to Buy According to Billionaires, including Eli Lilly and Company (LLY). Mizuho Securities America’s Jared Holz discussed the healthcare sector’s safe haven status amid market turmoil, citing factors like generic patent cliffs and price concessions affecting investor confidence.

Managed care companies, particularly US-based ones, are considered safe havens amidst economic slowdowns and tariffs, according to Holz. He suggested investors consider owning companies in this sector. Medical device stocks that are more US-centric were also viewed as having less risk compared to others, making them relatively safer investments.

Eli Lilly and Company (LLY) is among the 10 best medical stocks backed by billionaire investors. The pharmaceutical company has seen strong revenue growth and operational progress, with a focus on GLP-1 drugs for diabetes and obesity. Collaborations like the one with AdvanCell for cancer treatment aim to strengthen the company’s portfolio and explore innovative therapies.

Analysts like Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and Company (LLY), with a median price target indicating a 37.73% upside potential. Despite underperformance in the past, LLY remains a top choice among billionaire investors for its growth potential. However, some AI stocks may offer higher returns within a shorter timeframe, making them worth considering for investment opportunities.

Read more: Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires